// App-Quantinova.ai

ABS051 : ASSESSING THE BLEEDING PHENOTYPE IN NON‐SEVERE HEMOPHILIA BY USE OF THE ISTH BLEEDING ASSESSMENT TOOL (BAT)

Researchers

Presenter

  • F. R. Kloosterman

Principal Investigators

  • A.-F. Zwagemaker

  • S. C. Gouw

  • C. N. Bagot

  • P. Brons

  • M. H. Cnossen

  • P. Collins

  • K. Fischer

  • S. Jackson

  • K. Meijer

  • M. J. H. A. Kruip

  • F. W. G. Leebeek

  • B. Laros-van Gorkum

  • C. Male

  • I. Pabinger

  • M. Coppens

  • J. G. van der Bom

  • K. Fijnvandraat

Medical Centers

  • Paediatric Cardiology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

  • Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, Netherlands

  • Department of Pathology, Glasgow Royal Infirmary, Glasgow, United Kingdom

  • Department of Pediatric Hematology and Oncology, Radboud University Medical Center, Nijmegen, Netherlands

  • Division of Pediatric Infectious Diseases and Immunology,Erasmus University Medical Center - Sophia Childrens Hospital, Rotterdam,Netherlands

  • Arthur Bloom Haemophilia Centre, University Hospital of Wales School of Medicine, Cardiff, United Kingdom

  • Hematology and Van Creveld Cinic, University Medical Center Utrecht, Utrecht, Netherlands

  • Inherited Bleeding Disorders Program of BC ‐ Adult Division, St. Paul’s Hospital Vancouver British Columbia, Vancouver, Canada

  • Department of Paediatrics, University Medical Center Groningen, Groningen

  • Department of Hematology,Amsterdam University Medical Center, AMC,Amsterdam,Niederlande

  • Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands

  • First Department of Pediatrics

  • Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria

  • Department of Vascular Medicine, Amsterdam University Medical Centres, Amsterdam

  • Center for Clinical Transfusion Research, Sanquin‐Leiden University Medical Center, Leiden, Netherlands

  • Molecular Cellular Hemostasis, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands

Locations

  • Netherlands

  • United Kingdom

  • Canada

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • FVIII

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • NCT03623295

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved